Logo image of PMAX

POWELL MAX LTD-CL A (PMAX) Stock Fundamental Analysis

NASDAQ:PMAX - Nasdaq - VGG7200G1000 - Common Stock - Currency: USD

0.38  +0.01 (+2.7%)

Fundamental Rating

1

Overall PMAX gets a fundamental rating of 1 out of 10. We evaluated PMAX against 237 industry peers in the Capital Markets industry. PMAX has a bad profitability rating. Also its financial health evaluation is rather negative. PMAX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PMAX has reported negative net income.
PMAX had a negative operating cash flow in the past year.
PMAX Yearly Net Income VS EBIT VS OCF VS FCFPMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

The Return On Assets of PMAX (-28.57%) is worse than 90.72% of its industry peers.
With a Return On Equity value of -85.71%, PMAX is not doing good in the industry: 88.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -28.57%
ROE -85.71%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMAX Yearly ROA, ROE, ROICPMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 38.89%, PMAX is doing worse than 66.67% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for PMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMAX Yearly Profit, Operating, Gross MarginsPMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

PMAX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, PMAX has an improved debt to assets ratio.
PMAX Yearly Shares OutstandingPMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
PMAX Yearly Total Debt VS Total AssetsPMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that PMAX is in the distress zone and has some risk of bankruptcy.
PMAX's Altman-Z score of 1.38 is fine compared to the rest of the industry. PMAX outperforms 62.45% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that PMAX is somewhat dependend on debt financing.
The Debt to Equity ratio of PMAX (0.91) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACCN/A
WACCN/A
PMAX Yearly LT Debt VS Equity VS FCFPMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

PMAX has a Current Ratio of 1.45. This is a normal value and indicates that PMAX is financially healthy and should not expect problems in meeting its short term obligations.
PMAX has a Current ratio of 1.45. This is comparable to the rest of the industry: PMAX outperforms 59.07% of its industry peers.
A Quick Ratio of 1.45 indicates that PMAX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.45, PMAX is in line with its industry, outperforming 59.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
PMAX Yearly Current Assets VS Current LiabilitesPMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

The earnings per share for PMAX have decreased strongly by -353.70% in the last year.
Looking at the last year, PMAX shows a very negative growth in Revenue. The Revenue has decreased by -26.53% in the last year.
EPS 1Y (TTM)-353.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-26.53%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMAX Yearly Revenue VS EstimatesPMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PMAX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMAX Price Earnings VS Forward Price EarningsPMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMAX Per share dataPMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PMAX!.
Industry RankSector Rank
Dividend Yield N/A

POWELL MAX LTD-CL A

NASDAQ:PMAX (8/4/2025, 11:52:35 AM)

0.38

+0.01 (+2.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.43M
AnalystsN/A
Price TargetN/A
Short Float %5.63%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.62
P/FCF N/A
P/OCF N/A
P/B 2.65
P/tB 2.65
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.23
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.57%
ROE -85.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.89%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.56%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 1.38
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-353.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.53%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-309.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-283.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-254.71%
OCF growth 3YN/A
OCF growth 5YN/A